| Vessels encapsulating tumor clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma SL Renne, HY Woo, S Allegra, N Rudini, H Yano, M Donadon, L Viganò, ... Hepatology 71 (1), 183-195, 2020 | 144 | 2020 |
| Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children S Allegra, G Fatiguso, S De Francia, F Favata, E Pirro, C Carcieri, ... British journal of clinical pharmacology 84 (1), 197-203, 2018 | 48 | 2018 |
| Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms A D'Avolio, C Carcieri, J Cusato, M Simiele, A Calcagno, S Allegra, ... Journal of Antimicrobial Chemotherapy 69 (11), 3061-3066, 2014 | 47 | 2014 |
| UPLC–MS/MS method for the simultaneous quantification of anti-HBV nucleos (t) ides analogs: entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients A De Nicolò, M Simiele, D Pensi, L Boglione, S Allegra, G Di Perri, ... Journal of Pharmaceutical and Biomedical Analysis 114, 127-132, 2015 | 35 | 2015 |
| Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon L Boglione, J Cusato, S Allegra, I Esposito, F Patti, G Cariti, G Di Perri, ... Antiviral research 102, 35-43, 2014 | 35 | 2014 |
| NURR1 deficiency is associated to ADHD-like phenotypes in mice F Montarolo, S Martire, S Perga, M Spadaro, I Brescia, S Allegra, ... Translational Psychiatry 9 (1), 207, 2019 | 32 | 2019 |
| Pharmacogenetic of voriconazole antifungal agent in pediatric patients S Allegra, G Fatiguso, SD Francia, E Pirro, C Carcieri, J Cusato, ... Pharmacogenomics 19 (11), 913-925, 2018 | 29 | 2018 |
| Efavirenz pharmacogenetics in a cohort of Italian patients J Cusato, C Tomasello, M Simiele, A Calcagno, S Bonora, L Marinaro, ... International journal of antimicrobial agents 47 (2), 117-123, 2016 | 27 | 2016 |
| Influence of single-nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness J Cusato, S Allegra, D Massano, S De Francia, A Piga, A D'Avolio The Pharmacogenomics Journal 15 (3), 263-271, 2015 | 26 | 2015 |
| Vitamin D pathway gene variants and HCV-2/3 therapy outcomes J Cusato, S Allegra, L Boglione, AD Nicolò, L Baietto, G Cariti, GD Perri, ... Antiviral Therapy 20 (3), 335-341, 2015 | 25 | 2015 |
| Pharmacogenetics of ribavirin-induced anemia in HCV patients A D'Avolio, J Cusato, A De Nicolò, S Allegra, G Di Perri Pharmacogenomics 17 (8), 925-941, 2016 | 24 | 2016 |
| Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children S Allegra, G Fatiguso, S De Francia, F Favata, E Pirro, C Carcieri, ... Clinical and Experimental Pharmacology and Physiology 44 (11), 1083-1088, 2017 | 20 | 2017 |
| Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients S Allegra, J Cusato, A De Nicolò, L Boglione, A Gatto, G Cariti, G Di Perri, ... Biomedicine & Pharmacotherapy 69, 47-55, 2015 | 20 | 2015 |
| Precision medicine for HIV: where are we? J Cusato, S Allegra, AD Nicolò, A Calcagno, A D'Avolio Pharmacogenomics 19 (2), 145-165, 2018 | 19 | 2018 |
| Evaluation of posaconazole pharmacokinetics in adult patients with invasive fungal infection S Allegra, G Fatiguso, S De Francia, F Favata, E Pirro, C Carcieri, ... Biomedicines 5 (4), 66, 2017 | 17 | 2017 |
| Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients S Allegra, S De Francia, J Cusato, A Arduino, D Massano, F Longo, ... Pharmacogenomics 18 (6), 539-554, 2017 | 17 | 2017 |
| VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia J Cusato, S Allegra, L Boglione, A De Nicolò, G Cariti, G Di Perri, ... Pharmacogenetics and genomics 25 (4), 164-172, 2015 | 17 | 2015 |
| Effect of gender and age on voriconazole trough concentrations in Italian adult patients S Allegra, S De Francia, A De Nicolò, J Cusato, V Avataneo, A Manca, ... European journal of drug metabolism and pharmacokinetics 45, 405-412, 2020 | 16 | 2020 |
| A common mdr1 gene polymorphism is associated with changes in linezolid clearance S Allegra, A Di Paolo, J Cusato, G Fatiguso, E Arrigoni, R Danesi, ... Therapeutic Drug Monitoring 40 (5), 602-609, 2018 | 16 | 2018 |
| Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics S Allegra, G Fatiguso, A Calcagno, L Baietto, I Motta, F Favata, J Cusato, ... Pharmacogenomics 19 (9), 865-880, 2017 | 16 | 2017 |
